Addlife's CEO, Fredrik Dalborg, has increased his holdings in the life science company by purchasing 800 B-shares on December 5. The shares were acquired at a price of SEK 181.70 each, amounting to a total transaction value of SEK 145,400. The purchase was executed on Nasdaq Stockholm, according to the Swedish Financial Supervisory Authority's insider registry.
As of September 15, Dalborg owned 47,355 shares in Addlife, according to shareholder data service Holdings.

















